Initiating sacubitril/valsartan (LCZ696) in heart failure: results of TITRATION, a double-blind, randomized comparison of two uptitration regimens

Autor: Beata Sokolova, Alan Charney, Michele Senni, Jan Nociar, Hugh F. McIntyre, Fabian Chen, Bernard Reimund, Harinder Gogia, John J.V. McMurray, Manuel Martínez-Sellés, Rolf Wachter, Franco Cosmi, Peter Andreka, Antonio Reyes, Valeri Gelev, Ivan Majercak, Nina Shehova-Yankova, Mehmet Yilmaz, Zsolt Zilahi, Maurizio Volterrani, Arnab Sarkar, Enrique Galve, Steffen Fischer, Inder S. Anand, Maria Radomska, Juanjo J. Gómez-Doblas

Publikováno v: Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
European Journal of Heart Failure
ABACUS. Repositorio de Producción Científica
Universidad Europea (UEM)

WOS: 000383604800016
PubMed ID: 27170530
AimsTo assess the tolerability of initiating/uptitrating sacubitril/valsartan (LCZ696) from 50 to 200 mg twice daily (target dose) over 3 and 6 weeks in heart failure (HF) patients (ejection fraction

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1001e5d98e27a0a25404494b5ffe463
https://hdl.handle.net/20.500.12530/26550